In this study, we provide compelling evidence that supports a previously unidentified role of ICMT in the regulation of TAZ degradation via modulating the function of mutant KRAS and its downstream RAF–MEK signaling to support cancer cell self-renewal. The gene discussed is KRAS; the disease is cancer.